79 related articles for article (PubMed ID: 16778172)
1. Tal1 transgenic expression reveals absence of B lymphocytes.
Palamarchuk A; Zanesi N; Aqeilan RI; Efanov A; Maximov V; Santanam U; Hagan JP; Croce CM; Pekarsky Y
Cancer Res; 2006 Jun; 66(12):6014-7. PubMed ID: 16778172
[TBL] [Abstract][Full Text] [Related]
2. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
Ryan DP; Duncan JL; Lee C; Kuchel PW; Matthews JM
Proteins; 2008 Mar; 70(4):1461-74. PubMed ID: 17910069
[TBL] [Abstract][Full Text] [Related]
3. E2A activity is induced during B-cell activation to promote immunoglobulin class switch recombination.
Quong MW; Harris DP; Swain SL; Murre C
EMBO J; 1999 Nov; 18(22):6307-18. PubMed ID: 10562543
[TBL] [Abstract][Full Text] [Related]
4. Products of the TAL1 oncogene: basic helix-loop-helix proteins phosphorylated at serine residues.
Cheng JT; Hsu HL; Hwang LY; Baer R
Oncogene; 1993 Mar; 8(3):677-83. PubMed ID: 8437851
[TBL] [Abstract][Full Text] [Related]
5. Expression of the TAL1 proto-oncogene in cultured endothelial cells and blood vessels of the spleen.
Hwang LY; Siegelman M; Davis L; Oppenheimer-Marks N; Baer R
Oncogene; 1993 Nov; 8(11):3043-6. PubMed ID: 8414504
[TBL] [Abstract][Full Text] [Related]
6. Akt phosphorylates Tal1 oncoprotein and inhibits its repressor activity.
Palamarchuk A; Efanov A; Maximov V; Aqeilan RI; Croce CM; Pekarsky Y
Cancer Res; 2005 Jun; 65(11):4515-9. PubMed ID: 15930267
[TBL] [Abstract][Full Text] [Related]
7. Age-related differences in the E2A-encoded transcription factor E47 in bone marrow-derived B cell precursors and in splenic B cells.
Frasca D; Van Der Put E; Riley RL; Blomberg BB
Exp Gerontol; 2004 Apr; 39(4):481-9. PubMed ID: 15050281
[TBL] [Abstract][Full Text] [Related]
8. Proviral activation of the tumor suppressor E2a contributes to T cell lymphomagenesis in EmuMyc transgenic mice.
Mikkers H; Allen J; Berns A
Oncogene; 2002 Sep; 21(43):6559-66. PubMed ID: 12242653
[TBL] [Abstract][Full Text] [Related]
9. Impaired lymphocyte development and function in Clast5/Stra13/DEC1-transgenic mice.
Seimiya M; Wada A; Kawamura K; Sakamoto A; Ohkubo Y; Okada S; Hatano M; Tokuhisa T; Watanabe T; Saisho H; Tagawa M; O-Wang J
Eur J Immunol; 2004 May; 34(5):1322-32. PubMed ID: 15114665
[TBL] [Abstract][Full Text] [Related]
10. E2A proteins: essential regulators at multiple stages of B-cell development.
Kee BL; Quong MW; Murre C
Immunol Rev; 2000 Jun; 175():138-49. PubMed ID: 10933599
[TBL] [Abstract][Full Text] [Related]
11. Impaired V(D)J recombination and increased apoptosis among B cell precursors in the bone marrow of c-Abl-deficient mice.
Lam QL; Lo CK; Zheng BJ; Ko KH; Osmond DG; Wu GE; Rottapel R; Lu L
Int Immunol; 2007 Mar; 19(3):267-76. PubMed ID: 17229817
[TBL] [Abstract][Full Text] [Related]
12. Gradient of E2A activity in B-cell development.
Herblot S; Aplan PD; Hoang T
Mol Cell Biol; 2002 Feb; 22(3):886-900. PubMed ID: 11784864
[TBL] [Abstract][Full Text] [Related]
13. NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia.
Kusy S; Gerby B; Goardon N; Gault N; Ferri F; Gérard D; Armstrong F; Ballerini P; Cayuela JM; Baruchel A; Pflumio F; Roméo PH
J Exp Med; 2010 Sep; 207(10):2141-56. PubMed ID: 20855495
[TBL] [Abstract][Full Text] [Related]
14. TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB.
O'Neil J; Shank J; Cusson N; Murre C; Kelliher M
Cancer Cell; 2004 Jun; 5(6):587-96. PubMed ID: 15193261
[TBL] [Abstract][Full Text] [Related]
15. Tal1 regulates osteoclast differentiation through suppression of the master regulator of cell fusion DC-STAMP.
Courtial N; Smink JJ; Kuvardina ON; Leutz A; Göthert JR; Lausen J
FASEB J; 2012 Feb; 26(2):523-32. PubMed ID: 21990371
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of a transcription factor LYL1 induces T- and B-cell lymphoma in mice.
Zhong Y; Jiang L; Hiai H; Toyokuni S; Yamada Y
Oncogene; 2007 Oct; 26(48):6937-47. PubMed ID: 17486074
[TBL] [Abstract][Full Text] [Related]
17. TAL1/SCL is downregulated upon histone deacetylase inhibition in T-cell acute lymphoblastic leukemia cells.
Cardoso BA; de Almeida SF; Laranjeira AB; Carmo-Fonseca M; Yunes JA; Coffer PJ; Barata JT
Leukemia; 2011 Oct; 25(10):1578-86. PubMed ID: 21647153
[TBL] [Abstract][Full Text] [Related]
18. The chicken Ig light chain 3'-enhancer is essential for gene expression and regulates gene conversion via the transcription factor E2A.
Conlon TM; Meyer KB
Eur J Immunol; 2006 Jan; 36(1):139-48. PubMed ID: 16342328
[TBL] [Abstract][Full Text] [Related]
19. Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells.
Hsu HL; Wadman I; Baer R
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3181-5. PubMed ID: 8159721
[TBL] [Abstract][Full Text] [Related]
20. Evolution of vertebrate E protein transcription factors: comparative analysis of the E protein gene family in Takifugu rubripes and humans.
Hikima J; Lennard ML; Wilson MR; Miller NW; Clem LW; Warr GW
Physiol Genomics; 2005 Apr; 21(2):144-51. PubMed ID: 15713784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
